![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » TEVA GRABS 20% MARKET SHARE OF ZOLOFT IN A WEEK
TEVA GRABS 20% MARKET SHARE OF ZOLOFT IN A WEEK
Within a week of launching its generic version, Teva has achieved a 20% share of the Zoloft market. Specifically, Teva's version accounted for 19.7% of last week' sales of the antidepressant originally made by Pfizer, according to IMS. Haaretz (http://www.haaretz.com/hasen/spages/756601.html)
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
21Oct